Abingworth Management Ltd. · London United Kingdom
Company Description
View Abingworth Management Ltd. Locations On A US Map
This link will open in a new window
This link will open in a new window Abingworth believes scientific excellence is worth investing in. The company is a venture capital firm focused on all stages of life science investments and health care businesses in Europe and the US. It typically invests from $20 million to $80 million over the life of its involvement, a span of time averaging three to eight years. Portfolio holdings include drug developers Avila Therapeutics and Dicerna Pharmaceuticals and orthopedic products maker Stanmore Implants. The company has invested in companies engaged in structural biology, neuroscience, cell biology, gene therapy, and health care services. Abingworth has about $1.25 billion under management; it has established seven funds since 1973. To read the full description, subscribe now.
Call Now at 866-464-3202 or Click here for a Free Hoover's Trial!
Key Abingworth Management Ltd. Financials
| Company Type | Private Single Location |
| Fiscal Year-End | June |
| Annual Sales (mil.) | $11.6 |
| Employees | 10 |
Abingworth Management Ltd. Executives
18 executives listed for Abingworth Management Ltd.'s London, location.
| Title | Name & Bio | Contact |
| Managing Director | Stephen Bunting | Network |
| President, Abingworth Management, Inc. | Jonathan MacQuitty | Network |
| CFO and Director, UK | James Abell | Network |
Competition
Competitive Landscape for Abingworth Management Ltd.
Demand is driven primarily by the pace of technological innovation and the number of companies created to commercialize new technologies. The profitability of individual companies depends on successfully choosing and managing a portfolio of investments. Large companies have advantages in attracting investors, developing expertise in multiple technology markets, and funding large deals. Small companies can compete effectively by concentrating on specific market sectors or geographic areas. The average venture capital investment is about $8 million. Individual, or angel, investors, and large companies with strategic interests in early-stage companies are also sources of new venture funding. To read the full description, subscribe now.Top Abingworth Management Ltd. Competitors
Call Now at 866-464-3202 or Click here for a Free Hoover's Trial!